What is a stock summary page? Click here for an overview.
Business Description
Asymchem Laboratories Tianjin Co Ltd
ISIN : CNE100004Z06
Share Class Description:
STU:7K90: Class HCompare
Compare
Traded in other countries / regions
002821.China06821.Hong Kong7K90.Germany IPO Date
2023-01-12Description
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 22.57 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.3 | |||||
Interest Coverage | 73.88 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 7.33 | |||||
Beneish M-Score | -2.49 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EBITDA Growth Rate | 2.7 | |||||
3-Year EPS without NRI Growth Rate | -4.2 | |||||
3-Year Book Growth Rate | 10.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 20.69 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.48 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.91 | |||||
9-Day RSI | 27.02 | |||||
14-Day RSI | 30.39 | |||||
3-1 Month Momentum % | 13.56 | |||||
6-1 Month Momentum % | 7.2 | |||||
12-1 Month Momentum % | -3.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.46 | |||||
Quick Ratio | 5.77 | |||||
Cash Ratio | 4.29 | |||||
Days Inventory | 116.22 | |||||
Days Sales Outstanding | 108.98 | |||||
Days Payable | 49.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.87 | |||||
Dividend Payout Ratio | 0.66 | |||||
3-Year Dividend Growth Rate | 61.3 | |||||
Forward Dividend Yield % | 4.87 | |||||
5-Year Yield-on-Cost % | 39.64 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 2.52 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.36 | |||||
Operating Margin % | 12.1 | |||||
Net Margin % | 16.35 | |||||
FCF Margin % | 2.12 | |||||
ROE % | 5.59 | |||||
ROA % | 4.92 | |||||
ROIC % | 6.26 | |||||
3-Year ROIIC % | -11.85 | |||||
ROC (Joel Greenblatt) % | 14.97 | |||||
ROCE % | 6.17 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.35 | |||||
Forward PE Ratio | 11.55 | |||||
PE Ratio without NRI | 23.58 | |||||
Shiller PE Ratio | 21.29 | |||||
PEG Ratio | 1 | |||||
PS Ratio | 3.98 | |||||
PB Ratio | 1.43 | |||||
Price-to-Tangible-Book | 1.48 | |||||
Price-to-Free-Cash-Flow | 198.48 | |||||
Price-to-Operating-Cash-Flow | 18.54 | |||||
EV-to-EBIT | 14.75 | |||||
EV-to-EBITDA | 14.75 | |||||
EV-to-Revenue | 2.75 | |||||
EV-to-FCF | 128.34 | |||||
Price-to-GF-Value | 0.76 | |||||
Price-to-Projected-FCF | 1.32 | |||||
Price-to-DCF (Earnings Based) | 0.75 | |||||
Price-to-DCF (FCF Based) | 17.2 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.01 | |||||
Price-to-Graham-Number | 1.33 | |||||
Price-to-Net-Current-Asset-Value | 2.8 | |||||
Price-to-Net-Cash | 4.93 | |||||
Earnings Yield (Greenblatt) % | 6.78 | |||||
FCF Yield % | 0.54 | |||||
Forward Rate of Return (Yacktman) % | 21.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Asymchem Laboratories Tianjin Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 747.029 | ||
EPS (TTM) (€) | 0.346 | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | 60.38 | ||
14-Day RSI | 30.39 | ||
14-Day ATR (€) | 0.19788 | ||
20-Day SMA (€) | 5.8115 | ||
12-1 Month Momentum % | -3.6 | ||
52-Week Range (€) | 4.32 - 8.75 | ||
Shares Outstanding (Mil) | 360.6 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Asymchem Laboratories Tianjin Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Asymchem Laboratories Tianjin Co Ltd Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
Asymchem Laboratories Tianjin Co Ltd Frequently Asked Questions
What is Asymchem Laboratories Tianjin Co Ltd(STU:7K90)'s stock price today?
The current price of STU:7K90 is €4.78. The 52 week high of STU:7K90 is €8.75 and 52 week low is €4.32.
When is next earnings date of Asymchem Laboratories Tianjin Co Ltd(STU:7K90)?
The next earnings date of Asymchem Laboratories Tianjin Co Ltd(STU:7K90) is .
Does Asymchem Laboratories Tianjin Co Ltd(STU:7K90) pay dividends? If so, how much?
The Dividend Yield %  of Asymchem Laboratories Tianjin Co Ltd(STU:7K90) is 4.87% (As of Today), Highest Dividend Payout Ratio of Asymchem Laboratories Tianjin Co Ltd(STU:7K90) was 0.75. The lowest was 0.09. And the median was 0.19. The  Forward Dividend Yield % of Asymchem Laboratories Tianjin Co Ltd(STU:7K90) is 4.87%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |